Andrew Behm, PharmD
Advertisement
Articles by Andrew Behm, PharmD
Advertisement
Latest Updated Articles
- Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy
Published: November 1st 2003 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
How Medicaid Reforms Could Deepen State Coverage Gaps
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
